We are live on ! Find out more
IART icon

Integra LifeSciences

208 hedge funds and large institutions have $897M invested in Integra LifeSciences in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 75 increasing their positions, 63 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 63

1.14% less ownership

Funds ownership: 95.2%94.06% (-1.1%)

5% less funds holding

Funds holding: 219208 (-11)

18% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 44

45% less capital invested

Capital invested by funds: $1.62B → $897M (-$720M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
36
Increased
75
Reduced
63
Closed
44
Calls
$340K
Puts
Net Calls
+$340K
Net Calls Change
-$100K
Name Holding Trade Value Shares
Change
Change in
Stake
DFCM
51
Dark Forest Capital Management
Puerto Rico
$2.09M +$2.24M +154,109 +956%
Barclays
52
Barclays
United Kingdom
$2.06M +$225K +15,497 +10%
SOADOR
53
State of Alaska Department of Revenue
Alaska
$1.7M +$683K +47,012 +52%
WG
54
Winton Group
United Kingdom
$1.69M -$166K -11,402 -8%
OCM
55
Olstein Capital Management
New York
$1.66M +$537K +37,000 +38%
Ameriprise
56
Ameriprise
Minnesota
$1.63M -$233K -16,018 -11%
Swiss National Bank
57
Swiss National Bank
Switzerland
$1.63M -$27.6K -1,900 -1%
Nordea Investment Management
58
Nordea Investment Management
Sweden
$1.59M -$5.9K -406 -0.3%
TC
59
Tejara Capital
United Kingdom
$1.58M +$1.07M +73,386 +133%
Axa
60
Axa
France
$1.45M
AQR Capital Management
61
AQR Capital Management
Connecticut
$1.32M +$656K +45,200 +72%
EGM
62
Engineers Gate Manager
New York
$1.16M +$1.38M +94,793 New
STA
63
Summit Trail Advisors
New York
$1.14M +$1.35M +92,944 New
EEL
64
Expect Equity LLC
Maryland
$1.13M
QT
65
Quantbot Technologies
New York
$1.13M +$1.04M +71,888 +363%
Thrivent Financial for Lutherans
66
Thrivent Financial for Lutherans
Minnesota
$1.12M +$5.81K +400 +0.4%
MCM
67
Moore Capital Management
New York
$1.08M +$1.28M +88,210 New
New York State Teachers Retirement System (NYSTRS)
68
New York State Teachers Retirement System (NYSTRS)
New York
$1.08M +$24.1K +1,662 +2%
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$1.05M -$118K -8,127 -9%
AllianceBernstein
70
AllianceBernstein
Tennessee
$985K -$38.1M -2,626,194 -97%
QCM
71
Quantinno Capital Management
New York
$950K -$1.32M -90,888 -54%
Universal-Beteiligungs- und Servicegesellschaft
72
Universal-Beteiligungs- und Servicegesellschaft
Germany
$931K
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$909K +$937K +64,523 +674%
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
$878K -$11.2K -772 -1%
WCM
75
Wedge Capital Management
North Carolina
$860K +$11.6K +801 +1%

IART Hedge Fund Activity: Q2 2025 in Review

208 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2025, worth a combined $897M — down 45% from $1.62B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IART and 36 opened new positions — a net loss of 8 holders — while 63 trimmed existing stakes and 75 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $39.4M. The largest seller was AllianceBernstein, cutting an estimated $38.1M.

  • 208 institutional investors held Integra LifeSciences (IART) as of Q2 2025, down from 219 in Q1 2025.
  • Funds reported $897M of Integra LifeSciences stock for Q2 2025, down 45% quarter-over-quarter.
  • 36 funds opened new Integra LifeSciences positions in Q2 2025 and 44 closed out, a net change of -8 holders.
  • The largest Integra LifeSciences buyer in Q2 2025 was Rubric Capital Management (New York), an estimated $39.4M added.
  • The largest Integra LifeSciences seller in Q2 2025 was AllianceBernstein, an estimated $38.1M sold.

Based on aggregated 13F filings for Q2 2025.